Predictive bioactivity modeling and structural binding analysis for the identification of potential SMYD3 modulators

Related articles

1. Predicting Anticancer Targets of Mebendazole Through Network Pharmacology: An Integrated Analysis of Molecular Targets, Signalling Pathways, and Clinical Trial Evidence

   This article has 2 authors:

   1. Vijaykumar D Nimbarte
   2. Sharda Ishwarkar

2. Computational Design and Evaluation of MAO-B Inhibitors for Parkinson’s Disease: Molecular Docking, Qsar Model Pharmacophore Modeling and Admet Prediction

   This article has 6 authors:

   1. Aiman Haidri Aiman Haidri
   2. Krishna Kumar Krishna Kumar
   3. Mohit Kumar Mohit Kumar
   4. Ruchi Kant Ruchi Kant
   5. Aman Kumar
   6. Anshi Anshi

3. Development of Potential CDK9 Inhibitors through Pharmacophore-Based Virtual Screening, 3D-QSAR, Molecular Docking, MD Simulation, and In Vitro Anticancer Evaluation

   This article has 9 authors:

   1. Rajkumar Reddy Rajula
   2. Umadevi Etikyala
   3. Dinesha P
   4. Sampat P V
   5. Shreeganesh Subraya Hedge
   6. Muzaffar-Ur-Rehman Mohammed
   7. Chandra Sekhar Kondapalli Venkata Gowri
   8. Udayakumar Dalimba
   9. Vijjulatha Manga